Key Stats for Baldwin Insurance Stock
- Past-Week Performance: +0.1%
- 52-Week Range: $15.9 to $47.2
- Current Price: $21.1
What Happened?
Baldwin Insurance Group (BWIN), a vertically integrated insurance distributor that both brokers policies and manufactures its own insurance products, now trades 55% below its 52-week high of $47.15 at $21.06, even as the company guided 2026 revenue above $2.0B for the first time.
BWIN’s Q4 2025 results showed total revenue of $347.3M against a $352.3M consensus estimate, a miss driven by a 22% decline in profit-sharing revenue and a 1,530 basis-point swing in rate and exposure headwinds in the commercial insurance advisory segment, while adjusted EPS of $0.31 beat the $0.29 estimate.
The operational proof that the platform works sits in the Underwriting, Capacity and Technology Solutions segment, Baldwin’s proprietary insurance product manufacturing arm, which grew operating income 46% on 16% revenue growth in 2025, while the company signed a 10-year exclusive partnership with Fairway Independent Mortgage Corporation on February 25, the sixth largest independent U.S. mortgage lender.
CEO Trevor Baldwin stated on the Q4 2025 earnings call that “at 8x EBITDA, there is not a better use of capital than buying our own shares,” directly connecting the $250M share repurchase program authorized by the Board to what management views as a significant discount to intrinsic value.
With the 3B30 Catalyst program targeting $3B in revenue and a 30% adjusted EBITDA margin, $43M in CAC Group cost synergies being executed ahead of schedule with 60% already actioned within two months of closing, and organic growth guided to reach double digits by Q4 2026, the platform’s forward trajectory rests on three converging drivers that the current price does not yet reflect.
Wall Street’s Take on BWIN Stock
The Q4 revenue miss was driven entirely by timing-related profit-sharing declines and a rate and exposure swing in commercial insurance advisory, both of which carry finite end dates, making the miss a distraction from the underlying margin story.
Consensus models 2026 EBITDA of $470M on revenue of $2.01B, a 33.5% revenue jump driven by the CAC Group consolidation, with EBITDA margin expanding from 22.7% in 2025 to 23.2%, supported by $43M in CAC cost synergies that management has already actioned 60% of within two months of closing.
Meanwhile, normalized EPS is forecast to reach $2 in 2026 and $2.55 in 2027, a 27.1% step-up in the second year that reflects the point at which CAC synergies fully earn in and the QBE commission headwind in the embedded homebuilder channel rolls off after April 2026.
The Street’s 9 analysts covering BWIN currently show 5 buys, 1 outperform, 4 holds, and 0 sells, with a mean price target of $30.22 implying 43.5% upside from the current $21.06, a consensus that has been cut nearly in half since December 2024’s $50.86 mean target yet remains deeply bullish relative to where the stock actually trades.
The spread between the $21.00 low target and the $40.00 high target reflects a binary read on execution: bears anchoring to the pattern of organic growth misses and 4.1x leverage, bulls anchoring to the Fairway 10-year exclusive partnership signed February 25 and the embedded platform’s structural insulation from AI disintermediation.
What Does the Valuation Model Say?
TIKR’s mid-case model prices BWIN at $36.14 by December 2030, implying a 71.6% total return over 5.8 years at an 11.9% annualized IRR, driven by a mid-case revenue CAGR of 13.1% and net income margin expanding from 12.7% to 15.8%.
The market is pricing BWIN as a leverage-heavy acquirer with a broken organic growth track record, but EBITDA margin has expanded every year since 2021 from 19.9% to 22.7%, a trend the current price does not credit.
The CAC integration running ahead of schedule, with $32M of closed new business already booked in 2026 versus $20M in the prior year period, directly justifies the TIKR model’s 13.1% revenue CAGR and $36.14 price target.
Management authorizing a $250M buyback at what the CEO explicitly called 8x EBITDA, while stating there is “not a better use of capital,” signals conviction that the current price is a dislocation, not a reset.
The risk that breaks the model is a failure of organic growth to reach double digits by Q4 2026 as guided, which would expose the revenue CAGR assumption as acquisition-dependent and make the leverage at 4.1x unsustainable at current interest costs.
Q1 2026 earnings are the first confirmation point: watch whether organic revenue growth tracks above the low single-digit guidance and whether adjusted EBITDA lands within the $130M to $140M range management committed to.
Should You Invest in The Baldwin Insurance Group, Inc.?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up BWIN stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track The Baldwin Insurance Group, Inc. alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze BWIN stock on TIKR for Free →
